Get the Stockscreener App
27.78
0.47%
0.13
After Hours:
27.78
Collegium Pharmaceutical Inc stock is traded at $27.78, with a volume of 240.60K.
It is up +0.47% in the last 24 hours and down -1.28% over the past month.
Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.
See More
Previous Close:
$27.65
Open:
$27.56
24h Volume:
240.60K
Relative Volume:
0.65
Market Cap:
$863.38M
Revenue:
$566.77M
Net Income/Loss:
$48.16M
P/E Ratio:
23.34
EPS:
1.19
Net Cash Flow:
$274.29M
1W Performance:
+3.39%
1M Performance:
-1.28%
6M Performance:
-16.88%
1Y Performance:
-25.94%
1-Day Range:
$27.52
$28.19
1-Week Range:
$26.16
$28.19
52-Week Range:
$23.23
$42.29
Collegium Pharmaceutical Inc Stock (COLL) Company Profile
Name
Collegium Pharmaceutical Inc
Sector
Phone
781-713-3699
Address
100 TECHNOLOGY CENTER DRIVE, STOUGHTON, MA
Compare COLL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
COLL
Collegium Pharmaceutical Inc
|
27.78 | 863.38M | 566.77M | 48.16M | 274.29M | 1.19 |
|
ZTS
Zoetis Inc
|
158.06 | 68.50B | 9.26B | 2.49B | 2.30B | 5.47 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.38 | 47.71B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
HLN
Haleon Plc Adr
|
10.63 | 46.12B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.39 | 18.55B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
298.70 | 13.40B | 2.76B | 1.11B | 898.10M | 22.77 |
Collegium Pharmaceutical Inc Stock (COLL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-10-25 | Upgrade | Needham | Hold → Buy |
| Jul-30-24 | Upgrade | H.C. Wainwright | Neutral → Buy |
| Jun-07-24 | Upgrade | Jefferies | Hold → Buy |
| May-10-24 | Downgrade | Needham | Buy → Hold |
| May-10-24 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jan-04-24 | Downgrade | Jefferies | Buy → Hold |
| Aug-25-23 | Reiterated | Needham | Buy |
| May-02-23 | Resumed | Jefferies | Buy |
| Aug-08-22 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Feb-15-22 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
| Aug-06-21 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Jan-11-21 | Reiterated | H.C. Wainwright | Buy |
| Jul-14-20 | Initiated | BWS Financial | Sell |
| May-27-20 | Initiated | Guggenheim | Neutral |
| Feb-19-20 | Resumed | Jefferies | Buy |
| Oct-30-19 | Reiterated | Needham | Buy |
| May-03-19 | Resumed | H.C. Wainwright | Buy |
| Apr-12-19 | Resumed | Janney | Buy |
| Mar-20-19 | Initiated | SunTrust | Hold |
| Jan-16-19 | Reiterated | Needham | Buy |
| Mar-08-18 | Reiterated | H.C. Wainwright | Buy |
| Feb-07-18 | Reiterated | Needham | Buy |
| Dec-05-17 | Reiterated | Needham | Buy |
| Sep-11-17 | Initiated | H.C. Wainwright | Buy |
| May-11-17 | Reiterated | Needham | Buy |
| Sep-13-16 | Initiated | Gabelli & Co | Buy |
| Jun-01-15 | Initiated | Jefferies | Buy |
| Jun-01-15 | Initiated | Needham | Buy |
| Jun-01-15 | Initiated | Piper Jaffray | Overweight |
View All
Collegium Pharmaceutical Inc Stock (COLL) Latest News
BlackRock, Inc. Reduces Stake in Collegium Pharmaceutical Inc. - GuruFocus
Wells Fargo & Company MN Sells 9,987 Shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
Collegium Pharmaceutical (COLL) Expected to Beat Earnings Estimates: Should You Buy? - Yahoo Finance
Collegium Pharmaceutical (COLL) Projected to Post Earnings on Thursday - Defense World
Raymond James Financial Inc. Invests $2.43 Million in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
Press Release Distribution & PR Platform - ACCESS Newswire
Brokerages Set Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Price Target at $43.60 - Defense World
Collegium to Report First Quarter 2025 Financial Results on May 8, 2025 - GlobeNewswire
Collegium Pharmaceutical Q1 2025 Earnings Date Revealed: Key Financial Results Coming May 8 - Stock Titan
JPMorgan Chase & Co. Cuts Stock Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
Russell Investments Group Ltd. Trims Stock Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
Is Collegium Pharmaceutical (COLL) Stock Undervalued Right Now? - Yahoo Finance
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Shares Sold by Federated Hermes Inc. - Defense World
Collegium Pharmaceutical (NASDAQ:COLL) Rating Lowered to “Buy” at StockNews.com - Defense World
Geode Capital Management LLC Sells 5,098 Shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
Alliancebernstein L.P. Sells 66,120 Shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Shares Sold by LPL Financial LLC - Defense World
Trading (COLL) With Integrated Risk Controls - news.stocktradersdaily.com
Collegium Appoints Nancy S. Lurker to its Board of Directors - The Globe and Mail
2 Reasons to Watch COLL and 1 to Stay Cautious - Yahoo Finance
2 Reasons To Watch COLL And 1 To Stay Cautious - Barchart.com
Wellington Management Group LLP Cuts Stock Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
StockNews.com Upgrades Collegium Pharmaceutical (NASDAQ:COLL) to “Strong-Buy” - Defense World
Vanguard Group Inc. Sells 63,876 Shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
Collegium Pharmaceutical (NASDAQ:COLL) Earns “Buy” Rating from Needham & Company LLC - Defense World
Sei Investments Co. Has $294,000 Stock Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
What Analysts Are Saying About Collegium Pharmaceutical Stock - Benzinga
Corebridge Financial Inc. Decreases Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Stock Position Cut by American Century Companies Inc. - Defense World
Collegium Pharmaceutical (NASDAQ:COLL) Hits New 52-Week Low – Time to Sell? - Defense World
Prudential Financial Inc. Trims Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
Here's Why Collegium Pharmaceutical (NASDAQ:COLL) Has Caught The Eye Of Investors - simplywall.st
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Shares Sold by Thrivent Financial for Lutherans - Defense World
Is Collegium Pharmaceutical, Inc.'s (NASDAQ:COLL) 30% ROE Better Than Average? - Yahoo Finance
A Look Back at Branded Pharmaceuticals Stocks’ Q4 Earnings: Collegium Pharmaceutical (NASDAQ:COLL) Vs The Rest Of The Pack - Yahoo Finance
Teacher Retirement System of Texas Has $274,000 Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
Collegium to Participate in 24th Annual Needham Virtual Healthcare Conference - GlobeNewswire
Exclusive: Collegium Leaders Set for Key Investor Presentation at Needham Conference - Stock Titan
Analysts Set Collegium Pharmaceutical, Inc. (NASDAQ:COLL) PT at $43.60 - Defense World
HighTower Advisors LLC Has $428,000 Stock Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
Raymond James Financial Inc. Makes New Investment in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
Swiss National Bank Has $1.81 Million Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
HC Wainwright Has Optimistic Outlook of COLL Q3 Earnings - Defense World
Collegium to Present Real-World Data at PainConnect 2025, the American Academy of Pain Medicine’s Annual Meeting - GlobeNewswire
Q1 EPS Estimate for Collegium Pharmaceutical Cut by Analyst - Defense World
Avalo Therapeutics Appoints Michael Heffernan as Chairman of the Board - Yahoo Finance
Collegium Pharmaceutical (NASDAQ:COLL) Receives “Buy” Rating from HC Wainwright - Defense World
Collegium pharmaceutical CFO Colleen Tupper sells shares for $228,250 By Investing.com - Investing.com South Africa
Collegium Pharmaceutical EVP sells shares worth $624,794 - Investing.com India
Collegium Pharmaceutical EVP sells shares worth $624,794 By Investing.com - Investing.com Australia
Collegium Pharmaceutical Inc Stock (COLL) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.03%
0.06%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):